ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 33 filers reported holding ACASTI PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $71,000 | – | 29,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 687,985 | $224,000 | 0.02% |
MITCHELL MCLEOD PUGH & WILLIAMS INC | 45,000 | $15,000 | 0.01% |
Sterling Investment Advisors, Ltd. | 40,000 | $13,000 | 0.00% |
OPPENHEIMER & CO INC | 224,965 | $73,000 | 0.00% |
Renaissance Technologies | 1,924,000 | $625,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,500 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 174,593 | $56,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 37,600 | $12,000 | 0.00% |
TORONTO DOMINION BANK | 207 | $0 | 0.00% |